‘How can you understand life if you don’t look at it live?’ — Eikon Therapeutics rakes in $518M
TechCrunch
JANUARY 6, 2022
Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How can you understand life if you don’t look at it live? . “It It was such a simple statement, but it was kind of eye opening to me,” Goulburn tells TechCrunch.
Let's personalize your content